GFAP and Mental deterioration: To identify potential biomarkers for the early detection of cognitive decline, we first analyzed the plasma of participants in the NN, NI, and II groups for the protein expression levels of ASC (Figure 1A), NfL (Figure 1B), GFAP (Figure 1C), and Aβ42/40 ratio (Figure 1D).